SANGAMO THERAPEUTICS INC shareholders Q2 2023

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 151 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

SANGAMO THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
WASATCH ADVISORS LP 17,052,440$22,168,1720.13%
GSA CAPITAL PARTNERS LLP 806,954$1,0490.10%
GLOBEFLEX CAPITAL L P 697,583$906,8580.10%
Rokos Capital Management LLP 6,474,348$8,060,5630.08%
Long Focus Capital Management, LLC 1,272,000$1,653,6000.08%
KLK CAPITAL MANAGEMENT LLC 44,323$57,6190.07%
XTX Topco Ltd 257,658$334,9550.06%
Golden State Equity Partners 135,765$176,4950.05%
CAXTON ASSOCIATES LP 177,960$231,3480.03%
ExodusPoint Capital Management, LP 2,083,633$2,7090.02%
Fort Sheridan Advisors LLC 66,486$86,4320.02%
CORNERCAP INVESTMENT COUNSEL INC 90,265$117,3450.02%
Sandbox Financial Partners, LLC 24,833$32,2830.02%
ACADIAN ASSET MANAGEMENT LLC 2,821,980$3,6650.02%
Y-Intercept (Hong Kong) Ltd 98,590$128,1670.01%
Hudson Bay Capital Management LP 1,325,000$1,722,5000.01%
HRT FINANCIAL LP 741,806$9640.01%
Headlands Technologies LLC 17,944$23,3270.01%
MERITAGE PORTFOLIO MANAGEMENT 78,260$1020.01%
Grey Street Capital, LLC 10,000$13,0000.01%
External links

This page lists SANGAMO THERAPEUTICS INC's shareholders in Q2 2023. To view SANGAMO THERAPEUTICS INC's shareholder history, click here.